Angel / Venture
Health first: venture capital rushes into medical start-ups

Health first: venture capital rushes into medical start-ups

In an analysis of US medical venture funding across 17 areas of the human body, the industry set records in both the blood and immune system categories

Boards of Directors
Going Private Transactions

Going Private Transactions

Posted by Warren S. de Wied, Philip Richter, and Robert C. Schwenkel, Fried, Frank, Harris, Shriver & Jacobson LLP, on Saturday, April 18, 2020 Editor's Note: Warren S. de Wied, Philip Richter, and Robert C.

Pharma and Healthcare
PE firm buys anti-counterfeit specialist combatting rise in fake drugs amid Covid-19

PE firm buys anti-counterfeit specialist combatting rise in fake drugs amid Covid-19

Brussels-based Advanco provides tracking systems for serialised pharmaceutical products

Consumer Services
Apollo Global’s bet on Fresh Market gets a boost as consumers stock up

Apollo Global’s bet on Fresh Market gets a boost as consumers stock up

Private equity-backed specialty grocer is expecting an up to 11% increase in first quarter sales, report shows

Fintech and Finance
Wall Street banks set aside $19bn to handle virus crisis but it may not be enough

Wall Street banks set aside $19bn to handle virus crisis but it may not be enough

Analysts are quick to point to strong underlying earnings - but banks don't yet know how deep the recession, or even depression, will be

Politics
Danish buyout firm Axcel seals debut deal from sixth fund

Danish buyout firm Axcel seals debut deal from sixth fund

The firm has acquired Norwegian software company SuperOffice in a deal valued at €87m

Oil and Energy
BlackRock raises $5.1bn for new energy infrastructure fund

BlackRock raises $5.1bn for new energy infrastructure fund

The fund will focus on investing in power plants, pipelines and related businesses

Consumer Services
Clearlake closes sixth fund at nearly $7bn

Clearlake closes sixth fund at nearly $7bn

Opalesque Industry Update - Clearlake Capital Group, L.P., a leading investment firm that invests in the technology, industrials, and consumer sectors, today announced it has completed fundraising for its sixth private equity fund, Clearlake Capital

Oil and Energy
Hedge funds down 8.03% in March, but manage to outperform equity markets as coronavirus shakes markets and economies

Hedge funds down 8.03% in March, but manage to outperform equity markets as coronavirus shakes markets and economies

Opalesque Industry Update - The hedge fund industry tracked the fates of other markets and broader economies roiled by the novel coronavirus pandemic in March, posting an 8.03% loss for the month, according to the

Oil and Energy
Opalesque Exclusive: Corona Fighters Report 7: Asset managers who delivered through the meltdown

Opalesque Exclusive: Corona Fighters Report 7: Asset managers who delivered through the meltdown

Bailey McCann, Opalesque New York: Amid the current market turmoil, this is our regular report on hedge fund managers who are bucking the trend. Prior issues: Report 1; Report 2; Report 3; Report 4; Report

Europe
EU ignores science and puts damaging biofuels into Taxonomy

EU ignores science and puts damaging biofuels into Taxonomy

The European Union’s Taxonomy of Sustainable Economic Activities, the cornerstone of its action on sustainable finance, looks set to bless several technologies such as biofuels and hydroelectric power that are not just environmentally questionable but

COVID-19
The Impact of COVID19 on Shareholder Activism

The Impact of COVID19 on Shareholder Activism

Posted by Keith Gottfried and Sean Donahue, Morgan, Lewis & Bockius LLP, on Sunday, April 12, 2020 Editor's Note: Keith Gottfried and Sean Donahue are partners at Morgan, Lewis & Bockius LLP. This post is based on a

Software and Hi-Tech
MPs scrutinise whether Gilt syndications are cost-effective

MPs scrutinise whether Gilt syndications are cost-effective

The House of Commons' Treasury Select Committee has asked the UK Debt Management Office to answer a series of questions on its bond syndication programme, specifically on the pricing of its bonds and the fees

Consumer Services
Dada Nexus bags $450m from ADS follow-on, stock tanks

Dada Nexus bags $450m from ADS follow-on, stock tanks

Dada Nexus, which operates on-demand retail and delivery platforms in China, raised $450m this week after selling a chunk of new equity.

Fintech and Finance
China policy and markets round-up: Beijing finalises D-Sib rules, Caixin PMIs hit decade high, US bill to delist Chinese companies clears House

China policy and markets round-up: Beijing finalises D-Sib rules, Caixin PMIs hit decade high, US bill to delist Chinese companies clears House

In this round-up, China unveils guidelines to assess its domestic systemically important banks, both the November Caixin China manufacturing and general services Purchasing Managers’ Indexes beat expectations, and the US House of Representatives waves through

Software and Hi-Tech
LifeTech Scientific, Yeahka share sales net HK$1.9bn

LifeTech Scientific, Yeahka share sales net HK$1.9bn

Medical device maker LifeTech Scientific Corp tapped the Hong Kong market for HK$930m ($120m) in fresh equity on Thursday.

IPO
Blue Moon rises with Hong Kong listing rapidly covered

Blue Moon rises with Hong Kong listing rapidly covered

Blue Moon Group, a Chinese detergent maker, saw the book for its up to HK$9.8bn ($1.3bn) IPO covered within hours of opening on Friday.

Manufacturing and Industrial
Sritex to extend 2019 loan

Sritex to extend 2019 loan

Indonesian textile products manufacturer Sri Rejeki Isman, better known as Sritex, is planning to extend a dollar loan closed in 2019 by two years.

Politics
Germany underwhelms with second green bond amid US election volatility

Germany underwhelms with second green bond amid US election volatility

Germany received lacklustre demand for its second ever green bond on Wednesday. The sovereign had to contend with a big drop in Bund yields following uncertainty over the US election result.

India
Fosun-backed Gland Pharma readies Rp65bn IPO

Fosun-backed Gland Pharma readies Rp65bn IPO

Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.